pancreatic cancer

You have access
Enhanced Anti-tumor Effect of Flavopiridol in Combination With Gemcitabine in Pancreatic Cancer
KWANG HYUN CHUNG, IN RAE CHO, WOO HYUN PAIK, YONG-TAE KIM, SANG HYUB LEE and JI KON RYU

Anticancer Research March 2024, 44 (3) 1097-1108; DOI: https://doi.org/10.21873/anticanres.16905
You have access
A Retrospective Study of Gemcitabine Plus Nab-Paclitaxel for Advanced Pancreatic Cancer Refractory to Gemcitabine Monotherapy
MARIKO NISHIOKA, NAOHIRO OKANO, MASASHI WAKABAYASHI, TAKASHI IKENO, MASATO HAYASHI, TOMONORI MIZUTANI, FUMIO NAGASHIMA and JUNJI FURUSE

Anticancer Research March 2024, 44 (3) 1233-1239; DOI: https://doi.org/10.21873/anticanres.16919
You have access
Clinical Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgical Patients With Pancreatic Cancer
SHINNOSUKE KAWAHARA, TORU AOYAMA, MASAAKI MURAKAWA, REI KANEMOTO, DAISHI TAKAHASHI, YUTO KAMIOKA, ITARU HASHIMOTO, MARIKO KAMIYA, AYA KATO, YUKIO MAEZAWA, KEISUKE KAZAMA, SHO SAWAZAKI, HIROSHI TAMAGAWA, SATOSHI KOBAYASHI, MAKOTO UENO, NAOTO YAMAMOTO, TAKASHI OSHIMA, NORIO YUKAWA, YASUSHI RINO, AYA SAITO and SOICHIRO MORINAGA

Anticancer Research January 2024, 44 (1) 221-228; DOI: https://doi.org/10.21873/anticanres.16805
Open Access
Association of Pre-operative Geriatric Nutritional Risk Index With Complete Adjuvant Chemotherapy and Prognosis Post-pancreatectomy
TOSHIYA HIGASHI, KATSUTOSHI MURASE, RYOMA YOKOI, MASASHI KUNO, MASAHIRO FUKADA, JESSE YU TAJIMA, SHIGERU KIYAMA, YOSHIHIRO TANAKA, NAOKI OKUMURA and NOBUHISA MATSUHASHI

Anticancer Research January 2024, 44 (1) 427-434; DOI: https://doi.org/10.21873/anticanres.16828
You have access
Prognostic Value and the Immune Microenvironment-associated Role of SMAD4 in Pancreatic Adenocarcinoma
YIRAN SONG, YANG WANG, TIANYU YU, YAZHI HE, CHUNYAN WANG, FENG WANG and YINGQUN ZHOU

Anticancer Research December 2023, 43 (12) 5393-5408; DOI: https://doi.org/10.21873/anticanres.16743
You have access
PARP Inhibitor Sensitizes BRCA-mutant Pancreatic Cancer to Oxaliplatin by Suppressing the CDK1/BRCA1 Axis
CHORONG KIM, DANBEE KIM, DA SOL LEE, SEONMIN LEE, CHANGHOON YOO and KYU-PYO KIM

Anticancer Research December 2023, 43 (12) 5523-5534; DOI: https://doi.org/10.21873/anticanres.16754
Open Access
High Glucose-stimulated aPKC Activation Promotes Pancreatic Cancer Cell Progression Through YAP Signaling
TEPPEI SUNAGUCHI, YOSUKE HORIKOSHI, TAKEHIKO HANAKI, TERUHISA SAKAMOTO, KAZUHIRO NAKASO, CHIEKO SAKAI, KAZUNARI YAMASHITA, SHIGEO OHNO, YOSHIYUKI FUJIWARA and TATSUYA MATSURA

Anticancer Research November 2023, 43 (11) 4843-4853; DOI: https://doi.org/10.21873/anticanres.16681
You have access
Over-expression of cFos by the Transcription Factors NFATc2 and Sp1 in Pancreatic Cancer Cells
MANUELA MALSY, BERNHARD GRAF, ELISABETH BRUENDL, CONSTANTIN MAIER-STOCKER and ANIKA BUNDSCHERER

Anticancer Research November 2023, 43 (11) 4897-4904; DOI: https://doi.org/10.21873/anticanres.16687
Open Access
Sociodemographic Barriers to the Timely Treatment of Pancreatic Cancer
PAOLA BERRIOS JIMENEZ, REED POPP, SEEMA SHARAN, HARSHEEN K. MANAISE, SYEDA HOORULAIN AHMED, SHIVAM BANSAL, GABRIELLE KOWKABANY, SWATHI RAIKOT, KULKAEW BELLE SUKNIAM DO, ANTHONY GEORGE and EMMANUEL GABRIEL

Anticancer Research November 2023, 43 (11) 4969-4974; DOI: https://doi.org/10.21873/anticanres.16695
You have access
miR-122-5p Restrains Pancreatic Cancer Cell Growth and Causes Apoptosis by Negatively Regulating ASCT2
PING REN, NA WU, SHICHEN FU, WENBIN WANG, QI LI and QINGZHOU CHENG

Anticancer Research October 2023, 43 (10) 4379-4388; DOI: https://doi.org/10.21873/anticanres.16634

Main menu

User menu

Search

pancreatic cancer

Pages